Invention Grant
US07884219B2 Crystalline forms of [3-(4- {2-butyl- 1 -[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
有权
[3-（4- {2-丁基-1- [4-（4-氯 - 苯氧基） - 苯基] -1H-咪唑-4-基} - 苯氧基） - 丙基] - 二乙基胺的结晶形式
![Crystalline forms of [3-(4- {2-butyl- 1 -[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine](/docs/US/2011-02-08/US07884219B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of [3-(4- {2-butyl- 1 -[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
- Patent Title (中): [3-（4- {2-丁基-1- [4-（4-氯 - 苯氧基） - 苯基] -1H-咪唑-4-基} - 苯氧基） - 丙基] - 二乙基胺的结晶形式
-
Application No.: US12046872Application Date: 2008-03-12
-
Publication No.: US07884219B2Publication Date: 2011-02-08
- Inventor: Anitha Hari
- Applicant: Anitha Hari
- Applicant Address: US NC High Point
- Assignee: TransTech Pharma, Inc.
- Current Assignee: TransTech Pharma, Inc.
- Current Assignee Address: US NC High Point
- Main IPC: C07D209/44
- IPC: C07D209/44
![Crystalline forms of [3-(4- {2-butyl- 1 -[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine](/abs-image/US/2011/02/08/US07884219B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethylamine (“COMPOUND I”) useful in the treatment of RAGE mediated diseases.
Public/Granted literature
- US20080249316A1 CRYSTALLINE FORMS OF [3-(4- -PHENOXY)-PROPYL]-DIETHYL-AMINE Public/Granted day:2008-10-09
Information query
